Shopping Cart
Remove All
Your shopping cart is currently empty
Ginsenoside Rk1 has anti-tumor, and anti-platelet aggregation activities.


| Description | Ginsenoside Rk1 has anti-tumor, and anti-platelet aggregation activities. |
| In vitro | Their structure were determined to be 3beta,12beta-dihydroxydammar-20(21),24-diene-3-O-beta-D-glucopyranosyl(1 --> 2)-beta-D-glucopyranoside; 3beta,12beta-dihydroxydammar-20(21),24-diene-3-O-beta-D- glucopyranoside and 3beta,6alpha,12beta-trihydroxydammar-20(21),24-diene-6-O-beta-D-glucopyranoside based on spectroscopic evidences. |
| Molecular Weight | 604.869 |
| Formula | C36H60O7 |
| Cas No. | 364779-14-6 |
| Relative Density. | 1.17 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.